A group of scientists from Canada found that the non-coding part of the human genome, the so-called "junk" DNA, can be used for immunotherapy of cancer. They published their methodology in the journal Science Translational Medicine.


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.